Fulcrum Therapeutics

Fulcrum Therapeutics is a clinical‑stage biotechnology company that discovers and develops small molecules to modulate gene expression and address the root causes of genetically defined diseases. Their approach focuses on transcriptional regulation and restoring healthy gene programs through genetics‑driven target identification and proprietary discovery platforms. Fulcrum advances a pipeline of precision medicines across genetically defined indications while emphasizing translational science, patient impact, and a collaborative organizational culture.